These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 22146561)

  • 21. Muckle-Wells cryopyrinopathy: complex phenotyping and response to therapy in a new multiplex kindred.
    Headley AP; Cordingley F; Hawkins PN; Riminton DS
    Inflammation; 2014 Apr; 37(2):396-401. PubMed ID: 24150829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Muckle-Wells syndrome in an Indian family associated with NLRP3 mutation.
    Abdulla MC; Alungal J; Hawkins PN; Mohammed S
    J Postgrad Med; 2015; 61(2):120-2. PubMed ID: 25766347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Muckle-Wells syndrome effectively treated with canakinumab: is the recommended dosing schedule mandatory?
    Mueller SM; Itin P; Haeusermann P
    Dermatology; 2011; 223(2):113-8. PubMed ID: 21967869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel mutation in the CIAS1/NLRP3 gene associated with an unexpected phenotype of cryopyrin-associated periodic syndromes.
    Insalaco A; Prencipe G; Buonuomo PS; Ceccherini I; Bracaglia C; Pardeo M; Nicolai R; De Benedetti F
    Clin Exp Rheumatol; 2014; 32(1):123-5. PubMed ID: 24144430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of canakinumab in cryopyrin-associated periodic syndromes: results from a Spanish cohort.
    Anton J; Calvo I; Fernández-Martin J; Gamir ML; Merino R; Jimenez-Treviño S; Sevilla B; Cabades F; Bou R; Arostegui JI
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S67-71. PubMed ID: 26243511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Canakinumab for the treatment of cryopyrin-associated periodic syndromes.
    Walsh GM
    Drugs Today (Barc); 2009 Oct; 45(10):731-5. PubMed ID: 20069137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal involvement in secondary amyloidosis of Muckle-Wells syndrome: marked improvement of renal function and reduction of proteinuria after therapy with human anti-interleukin-1β monoclonal antibody canakinumab.
    Scarpioni R; Rigante D; Cantarini L; Ricardi M; Albertazzi V; Melfa L; Lazzaro A
    Clin Rheumatol; 2015 Jul; 34(7):1311-6. PubMed ID: 24510061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A variant Muckle-Wells syndrome with a novel mutation in CIAS1 gene responding to anakinra.
    Dalgic B; Egritas O; Sari S; Cuisset L
    Pediatr Nephrol; 2007 Sep; 22(9):1391-4. PubMed ID: 17486372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome.
    Koné-Paut I; Galeotti C
    Expert Rev Clin Immunol; 2015; 11(10):1083-92. PubMed ID: 26312542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Muckle-Wells Syndrome Across Four Generations in One Czech Family: Natural Course of the Disease.
    Fingerhutová Š; Fráňová J; Hlaváčková E; Jančová E; Procházková L; Beránková K; Tesařová M; Honsová E; Doležalová P
    Front Immunol; 2019; 10():802. PubMed ID: 31057541
    [No Abstract]   [Full Text] [Related]  

  • 31. Muckle-Wells syndrome and male hypofertility: a case series.
    Tran TA; Koné-Paut I; Marie I; Ninet J; Cuisset L; Meinzer U
    Semin Arthritis Rheum; 2012 Dec; 42(3):327-31. PubMed ID: 22512814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS).
    Kuemmerle-Deschner JB; Ramos E; Blank N; Roesler J; Felix SD; Jung T; Stricker K; Chakraborty A; Tannenbaum S; Wright AM; Rordorf C
    Arthritis Res Ther; 2011 Feb; 13(1):R34. PubMed ID: 21356079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muckle-Wells syndrome in Chinese patients: a single center case series.
    Wu D; Shen M
    Clin Rheumatol; 2017 Apr; 36(4):965-969. PubMed ID: 28028683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and Molecular Phenotypes of Low-Penetrance Variants of NLRP3: Diagnostic and Therapeutic Challenges.
    Kuemmerle-Deschner JB; Verma D; Endres T; Broderick L; de Jesus AA; Hofer F; Blank N; Krause K; Rietschel C; Horneff G; Aksentijevich I; Lohse P; Goldbach-Mansky R; Hoffman HM; Benseler SM
    Arthritis Rheumatol; 2017 Nov; 69(11):2233-2240. PubMed ID: 28692792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current status of understanding the pathogenesis and management of patients with NOMID/CINCA.
    Goldbach-Mansky R
    Curr Rheumatol Rep; 2011 Apr; 13(2):123-31. PubMed ID: 21538043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cryopyrin-associated periodic syndrome with joint destruction.
    Lequerré T; Vittecoq O; Saugier-Veber P; Goldenberg A; Patoz P; Frébourg T; Le Loët X
    Rheumatology (Oxford); 2007 Apr; 46(4):709-14. PubMed ID: 17178739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a variant in NLRP3 gene in a patient with Muckle-Wells syndrome: a case report and review of literature.
    Liu J; Zhang R; Yi Z; Lin Y; Chang H; Zhang Q
    Pediatr Rheumatol Online J; 2023 Feb; 21(1):15. PubMed ID: 36765385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cryopyrin-associated periodic syndromes].
    Quartier P; Rodrigues F; Georgin-Lavialle S
    Rev Med Interne; 2018 Apr; 39(4):287-296. PubMed ID: 29111302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of IL-1 inhibition on fatigue associated with autoinflammatory syndromes.
    Yadlapati S; Efthimiou P
    Mod Rheumatol; 2016; 26(1):3-8. PubMed ID: 26140469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cryopyrin-associated periodic syndromes: diagnosis and management.
    Miyamae T
    Paediatr Drugs; 2012 Apr; 14(2):109-17. PubMed ID: 22335455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.